Literature DB >> 15639276

Epidemiology of ovarian cancer: a status report.

Elizabeth R Bertone-Johnson1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15639276     DOI： 10.1016/S0140-6736(05)17716-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals.

Authors:  Chengbin Ma; Yan Liu; Wenying Zhang; Ping Liu
Journal:  Mol Biol Rep       Date:  2013-01-18       Impact factor: 2.316

2.  MicroRNA-126 affects ovarian cancer cell differentiation and invasion by modulating expression of vascular endothelial growth factor.

Authors:  Jianqiao Luo; Caidan Zhu; Hongya Wang; Li Yu; Jianwei Zhou
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

3.  XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Ruolin Li; Li Xie; Meng Li; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-11-20

4.  Bioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer.

Authors:  S Xinqiang; Z Mu; C Lei; L Y Mun
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

5.  Low fertility may be a significant determinant of ovarian cancer worldwide: an ecological analysis of cross- sectional data from 182 countries.

Authors:  Wenpeng You; Ian Symonds; Maciej Henneberg
Journal:  J Ovarian Res       Date:  2018-08-16       Impact factor: 4.234

6.  Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer.

Authors:  Wu Yong; Deng Yu; Zhu Jun; Duan Yachen; Weng Weiwei; Xu Midie; Ju Xingzhu; Wu Xiaohua
Journal:  Cell Death Dis       Date:  2018-08-28       Impact factor: 8.469

7.  Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses.

Authors:  Yong Wu; Lingfang Xia; Qinhao Guo; Jun Zhu; Yu Deng; Xiaohua Wu
Journal:  Cancer Manag Res       Date:  2020-06-30       Impact factor: 3.989

8.  Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.

Authors:  Sanjeev Kumar; Christopher S Bryant; Sreedhar Chamala; Aamer Qazi; Shelly Seward; Jagannath Pal; Christopher P Steffes; Donald W Weaver; Robert Morris; John M Malone; Masood A Shammas; Madhu Prasad; Ramesh B Batchu
Journal:  Mol Cancer       Date:  2009-04-22       Impact factor: 27.401

9.  HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway.

Authors:  Yong Wu; Qinhao Guo; Xingzhu Ju; Zhixiang Hu; Lingfang Xia; Yu Deng; Ping Zhao; Meng Zhang; Yang Shao; Shenglin Huang; Xianghuo He; Hao Wen; Xiaohua Wu
Journal:  Oncogene       Date:  2021-06-19       Impact factor: 9.867

10.  Staging recurrent ovarian cancer with (18)FDG PET/CT.

Authors:  Sanja Dragosavac; Sophie Derchain; Nelson M G Caserta; Gustavo DE Souza
Journal:  Oncol Lett       Date:  2012-12-13       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.